论文信息 - ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to residual oligometastases of NSCLC after EGFR TKI. - 字舞流文

ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to residual oligometastases of NSCLC after EGFR TKI.

T. Mok | F. Mo | C. Wong | A. Chang | R. Yeung | K. Lam | O. Chan | J. Li | F. Choi | Ki Wang